Vitamin D OP remote study
- Study HIC#:2000028035
- Last Updated:07/15/2021
The purpose of this study is to assess vitamin D as a therapeutic adjunct in the stimulant treatment of ADHD.
- Age18 years - 50 years
- GenderBoth
- Start Date06/04/2020
- End Date05/31/2025
Trial Purpose and Description
This study aims to determine whether acute calcitriol (versus placebo) administration enhances the neurocognitive effects of of current stimulant medications as measured by tasks of vigilance/attention, spatial working memory, and reversal learning in individuals with (attention deficit hyperactivity disorder (ADHD) using a randomized, double-blind, placebo controlled, within-subject, two-day study design
Eligibility Criteria
This study aims to determine whether acute calcitriol (versus placebo) administration enhances the neurocognitive effects of of current stimulant medications as measured by tasks of vigilance/attention, spatial working memory, and reversal learning in individuals with (attention deficit hyperactivity disorder (ADHD) using a randomized, double-blind, placebo controlled, within-subject, two-day study design.
